Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 32,045 | 27,470 | 24,668 | 25,787 | 23,332 |
| Cost of Goods | 4,948 | 4,331 | 3,628 | 2,631 | 2,640 |
| Gross Profit | 27,097 | 23,139 | 21,040 | 23,156 | 20,692 |
| Operating Expenses | 37,497 | 59,608 | 35,327 | 34,971 | 30,287 |
| Operating Income | -9,452 | -36,138 | -13,659 | -11,184 | -8,955 |
| Interest Expense | 4,322 | 5,018 | 3,153 | 3,358 | 4,784 |
| Other Income | 305 | -81 | 138 | -21 | -140 |
| Pre-tax Income | -13,469 | -41,237 | -16,674 | -14,563 | -13,879 |
| Income Tax | 550 | 348 | 328 | 25 | 70 |
| Net Income Continuous | -14,019 | -41,585 | -17,002 | -14,588 | -13,949 |
| Net Income | $-14,019 | $-41,585 | $-17,002 | $-14,588 | $-13,949 |
| EPS Basic Total Ops | -0.16 | -0.49 | -0.20 | -0.18 | -0.17 |
| EPS Basic Continuous Ops | -0.16 | -0.49 | -0.19 | -0.18 | -0.17 |
| EPS Diluted Total Ops | -0.16 | -0.49 | -0.20 | -0.18 | -0.17 |
| EPS Diluted Continuous Ops | -0.16 | -0.49 | -0.19 | -0.18 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.20 | -0.20 | -0.18 | -0.17 |
| EBITDA(a) | $-8,642 | $-35,338 | $-12,886 | $-10,481 | $-8,259 |